Connection

Alessandro Rambaldi to Primary Myelofibrosis

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Primary Myelofibrosis.
Alessandro Rambaldi
Connection Strength
2.375
Primary Myelofibrosis
  1. Detection of driver and subclonal mutations in myelofibrosis: clinical impact on pharmacologic and transplant based treatment strategies. Expert Rev Hematol. 2017 07; 10(7):627-636.
    View in: PubMed
    Score: 0.609
  2. Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. Am J Hematol. 2020 01; 95(1):E1-E3.
    View in: PubMed
    Score: 0.180
  3. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients. Cancer Med. 2019 08; 8(9):4089-4092.
    View in: PubMed
    Score: 0.175
  4. Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. Blood Cancer J. 2018 09 21; 8(10):89.
    View in: PubMed
    Score: 0.167
  5. Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia. Leuk Res. 2018 06; 69:100-102.
    View in: PubMed
    Score: 0.162
  6. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. Haematologica. 2018 09; 103(9):e392-e394.
    View in: PubMed
    Score: 0.162
  7. The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells. Am J Hematol. 2018 05; 93(5):615-622.
    View in: PubMed
    Score: 0.160
  8. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis. J Clin Oncol. 2018 02 01; 36(4):310-318.
    View in: PubMed
    Score: 0.158
  9. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. Leuk Res. 2017 12; 63:34-40.
    View in: PubMed
    Score: 0.156
  10. Inflammation and myeloproliferative neoplasms. J Autoimmun. 2017 Dec; 85:58-63.
    View in: PubMed
    Score: 0.153
  11. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. 2017 06 15; 129(24):3227-3236.
    View in: PubMed
    Score: 0.150
  12. Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients. Am J Hematol. 2016 09; 91(9):918-22.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.